Evidence map›Paper›PMID 41702906›Full record

ArticleNature communications2026

Strategically significant synthesis of conjugated porous organic polymers via retro diazotization chemistry.

Melek Sermin Ozer, Zafer Eroglu, Sermet Koyuncu, Onder Metin

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Melek Sermin OzerDepartment of Chemistry, College of Sciences, Koç University, Istanbul, Türkiye. melekozer@ku.edu.tr.ORCID http://orcid.org/0000-0003-4840-8542
Zafer ErogluDepartment of Chemistry, College of Sciences, Koç University, Istanbul, Türkiye.ORCID http://orcid.org/0000-0002-0601-2526
Sermet KoyuncuDepartment of Chemical Engineering, Çanakkale Onsekiz Mart University, Çanakkale, Türkiye.ORCID http://orcid.org/0000-0001-8352-8326
Onder MetinDepartment of Chemistry, College of Sciences, Koç University, Istanbul, Türkiye. ometin@ku.edu.tr.ORCID http://orcid.org/0000-0003-1622-4992

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To overcome the limitations of conventional conjugated porous organic polymer (CPOP) syntheses that require harsh conditions or metal catalysts and fail to introduce halogen substituents such as -Br and -I in a controlled manner, we present herein a strategically significant synthesis method based on bismuthene-catalyzed photoredox C-H arylation via in situ diazotization. This approach provides enhanced polymer chain growth with relatively high Mw (up to 322 kDa), ideal poly-dispersity, tunable optical properties (visible to NIR region), and enabling to access to a broad range of monomers with high tolerance for halogens. To gain deeper insight into the mechanism of C-C bond formation via bismuthene-catalyzed photoredox C-H arylation, control and scavenger experiments were performed. The results confirm that CPOP growth proceeds through a single-electron transfer pathway, forming linear or cross-linked networks. The resulting polymers exhibited efficient photocatalytic activity for the selective oxidation of styrene to benzaldehyde via singlet oxygen as the dominant reactive species, achieving > 99% conversion and selectivity under blue LED irradiation. Remarkably, halogen-containing CPOPs (-Br, -I) afforded higher yields and superior photocatalytic efficiency, attributed to the heavy-atom effect and defect generation, which collectively enhance visible-light absorption and charge separation.

Identifiers

PMID41702906
PMCPMC13036007

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.